Physician profile
Patrick B Hinfey
NPI 1588616460
$1,121.17
in general payments reported to CMS, 2019-2025
11 companies · $117 in 2025
The $117 reported for 2025 was more than what a typical Emergency Medicine provider received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.19 · 2020: $59.16 · 2021: $30.00 · 2022: $174 · 2023: $359 · 2024: $369 · 2025: $117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $845.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $845.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $254.79 | 2022-2025 | Veklury |
| Astrazeneca Pharmaceuticals LP | $244.58 | 2023 | Andexxa |
| Mindray Ds USA, INC. | $228.74 | 2023-2025 | Te7 Max, Te X |
| Abbvie INC. | $156.87 | 2021-2025 | |
| Alexion Pharmaceuticals, INC. | $80.00 | 2022 | |
| Janssen Pharmaceuticals, INC | $58.66 | 2020-2023 | Xarelto |
| Allergan, INC. | $31.45 | 2020 | |
| Ethicon US, LLC | $18.84 | 2025 | Dermabond Prineo |
| Bioxcel Therapeutics, INC. | $18.51 | 2023 | Igalmi |
| Novartis Pharmaceuticals Corporation | $15.54 | 2024 | |
| Csl Behring | $13.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Hinfey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.